News
-
-
-
-
-
-
-
PRESS RELEASE
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Bausch Health and Salix Pharmaceuticals announce XIFAXAN selected for drug price negotiation program with CMS for 2027. Details on XIFAXAN and safety information included -
-
-